Compounds > 3-hydroxy-3-methylglutaryl-coenzyme a

3-hydroxy-3-methylglutaryl-coenzyme a and Breast Cancer

3-hydroxy-3-methylglutaryl-coenzyme a has been researched along with Breast Cancer in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	2 (50.00)	2.80

Authors

Authors	Studies
Ding, H; Guo, D; Jia, Y; Liu, F; Shi, M; Sun, L; Wang, Y; Yang, P; Zhang, Y; Zhu, Z	1
Akamo, AJ; Akinloye, OA; Metibemu, DS; Okoye, JO; Omotuyi, IO	1
Dhople, VM; Kanugula, AK; Kotamraju, S; Ummanni, R; Völker, U	1
Altundag, K; Bulut, N; Dincer, M; Harputluoglu, H	1

Reviews

1 review(s) available for 3-hydroxy-3-methylglutaryl-coenzyme a and Breast Cancer

Article	Year
Associations of genetically proxied inhibition of HMG-CoA reductase, NPC1L1, and PCSK9 with breast cancer and prostate cancer. Breast cancer research : BCR, 2022, 02-12, Volume: 24, Issue:1 Topics: Acyl Coenzyme A; Breast Neoplasms; Cholesterol, LDL; Coenzyme A; Genome-Wide Association Study; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Membrane Transport Proteins; Mendelian Randomization Analysis; Oxidoreductases; Proprotein Convertase 9; Prostatic Neoplasms; Receptors, Estrogen	2022

Article

Year

Associations of genetically proxied inhibition of HMG-CoA reductase, NPC1L1, and PCSK9 with breast cancer and prostate cancer.

Breast cancer research : BCR, 2022, 02-12, Volume: 24, Issue:1

Topics: Acyl Coenzyme A; Breast Neoplasms; Cholesterol, LDL; Coenzyme A; Genome-Wide Association Study; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Membrane Transport Proteins; Mendelian Randomization Analysis; Oxidoreductases; Proprotein Convertase 9; Prostatic Neoplasms; Receptors, Estrogen

2022

Other Studies

3 other study(ies) available for 3-hydroxy-3-methylglutaryl-coenzyme a and Breast Cancer

Article	Year
In-silico HMG-CoA reductase-inhibitory and in-vivo anti-lipidaemic/anticancer effects of carotenoids from Spondias mombin. The Journal of pharmacy and pharmacology, 2021, Sep-07, Volume: 73, Issue:10 Topics: Acyl Coenzyme A; Anacardiaceae; Animals; Anticholesteremic Agents; Antineoplastic Agents, Phytogenic; beta Carotene; Breast; Breast Neoplasms; Carotenoids; Down-Regulation; Female; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperlipidemias; Hypolipidemic Agents; Lipids; Molecular Docking Simulation; Phytotherapy; Plant Extracts; Rats, Wistar; Xanthophylls	2021
Fluvastatin mediated breast cancer cell death: a proteomic approach to identify differentially regulated proteins in MDA-MB-231 cells. PloS one, 2014, Volume: 9, Issue:9 Topics: Acyl Coenzyme A; Anticholesteremic Agents; Apoptosis; Breast Neoplasms; Caspase 3; Cell Line, Tumor; Chromatography, High Pressure Liquid; Electrophoresis, Gel, Two-Dimensional; Epithelial-Mesenchymal Transition; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Indoles; Metabolic Networks and Pathways; Mevalonic Acid; Mitogen-Activated Protein Kinase 1; Proteome; Tandem Mass Spectrometry; Vimentin	2014
Statins may decrease skeletal-related events in breast cancer patients with bone metastases. Medical hypotheses, 2006, Volume: 67, Issue:5 Topics: Acyl Coenzyme A; Apoptosis; Bone and Bones; Bone Neoplasms; Breast Neoplasms; Cell Division; Cholesterol; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mevalonic Acid; Neoplasm Metastasis; Osteoclasts	2006